Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (<scp>PASI</scp>) than with the Dermatology Life Quality Index (<scp>DLQI</scp>)

Abstract

The decision to initiate biological treatment is more strongly associated with PASI than with DLQI. However, since the DLQI reflects both socio-economic costs and patient suffering better than PASI, the relevance of the DLQI may be underestimated in clinical practice.